| 21.4.2023 | Antifungal Properties of Capric acid, Monocaprin, and Monolaurin. Formulation Efficacy and Prevalence of Fungal Infections in Malawi | Sigríður Ruth Th. Barker 1997- |
| 25.4.2023 | Development of Aspirin Tablets with a Comparable Dissolution Profile to a Commercial Product | Una Þorsteinsdóttir 1999-; Jóhanna Lan 2001-; María Björk Pálsdóttir 2001- |
| 26.4.2023 | Development of caffeine tablets exhibiting similar dissolution profile to reference tablets | Magnús Gauti Úlfarsson 2000-; Einar Magnús Hjaltason 2001-; Urszula Bondarow 1998- |
| 24.4.2023 | Development of generic first-order release paracetamol tablets | Selma Pedersen Kjartansdóttir 2001-; Úrsúla Hanna K. Karlsdóttir 1996-; Hanna Margrét Jónsdóttir 1999- |
| 5.5.2025 | Development of Sodium Benzoate Tablets with Dual Burst Release: Hydrophilic Matrix System | Jóna María Ólafsdóttir 2000-; Thelma Aðalsteinsdóttir 2000-; Tinna Barkardóttir 2001- |
| 3.5.2024 | Development of Sodium Benzoate Tablets with Zero-order Sustained Release | Auguste Artúrsdóttir 2000-; Kristín Rós Sigmundsdóttir 1999-; Elizabeth Ósk Anjie Love 2000- |
| 22.4.2022 | Development of vaginal suppositories containing lipids with antimicrobial effects | Auður Óskarsdóttir Andreasen 1995- |
| 3.2.2022 | Development of zero-order release 200 mg ibuprofen tablets | Kristófer Haukur Hauksson 1996-; Ragnar Axel Adolfsson 1998-; Sveinn Hlynur Tómasson 1998-; Þorsteinn Gíslason 1998- |
| 3.2.2025 | Development of Zero-Order Release Diltiazem Tablets | Íris Lind Magnúsdóttir 2000-; Lovísa Halldórsdóttir 2002-; Nansý Davíðsdóttir 2002- |
| 15.2.2022 | Development of zero-order release paracetamol tablets | Katrín Þóra Gunnarsdóttir 1998-; Senía Guðmundsdóttir 1999-; Sigríður Ruth Th. Barker 1997-; Sóley Diljá Sigurðardóttir 1997- |
| 13.5.2022 | Development of zero-order release tablets using hydrophilic polymer matrices | Tryggvi Leó Guðmundsson 1999-; Sævar Hrafn Jóhannsson 1999-; Kinga Sofia Demény 1998-; Ingimar Jónsson 1998- |
| 18.2.2022 | Diclofenac sodium modified zero-order release tablets in a capsule | Rut Matthíasdóttir 1996-; Júlía Karítas Helgadóttir 1998-; Harpa Ýr Jóhannsdóttir 1995- |
| 8.1.2015 | Effect of mid-dose acetylsalicylic acid on thromboxane B2 and development of preeclampsia. A clinical trial | Sólveig Óskarsdóttir 1987- |
| 15.4.2025 | Evaluation of Salicylic Acid in Saliva for Therapeutic Drug Monitoring of Acetylsalicylic Acid | Anna Helga Kristjánsdóttir 1999- |
| 19.4.2024 | Formulating and Spray Drying Self-Emulsifying Drug Delivery System Containing Monocaprin and Monolaurin | Guðjón Bjarki Hildarson 1998- |
| 24.4.2023 | Formulation and Development of Diclofenac Sodium Tablets that Imitate the Dissolution Profile of Dimax Rapid® | Ívar Örn Jónsson 2001-; Björn Hrannar Brynjarsson 1997-; Telma Rún Magnúsdóttir 2000-; Kristín Brynjarsdóttir 1999- |
| 28.4.2025 | Formulation and Development of Double Burst Paracetamol Tablets | Sunneva Sævarsdóttir 2003-; Kristrún Lena Eyjólfsdóttir 2002-; Rósmarý Kristrín Sigurðardóttir 1998- |
| 24.2.2022 | Formulation and Development of Sodium Benzoate Tablets with Zero Order Sustained Release: Osmotic Controlled Drug Delivery & Hydrophilic Matrix System | Katrín Silja Gunnarsdóttir 1999-; Kristín Rún Gunnarsdóttir 1997-; Rakel Sif Kristjánsdóttir 1997-; Selma Rún Jóhannesdóttir 1997- |
| 12.4.2022 | Formulation development of extended-release sodium benzoate tablets | Unnur Ástrós Magnúsdóttir 1999-; Sólrún Ágústsdóttir 1998-; Svana Björk Steinarsdóttir 1999- |
| 21.4.2023 | Formulation development of ibuprofen tablets: Formulation of ibuprofen tablets with the same drug release profile as Íbúfen® | Karitas Ýr Jakobsdóttir 2000-; Anna Helga Kristjánsdóttir 1999-; Ingibjörg Andrésdóttir 1998-; María Rós Guðmundsdóttir 2001- |
| 12.4.2022 | Formulation of controlled release ibuprofen oral dosage form | Þórdís Danielsdóttir van der Lint 1997-; Steinunn Benediktsdóttir 1999-; Brynjar Atli Bragason 2000-; Þórhildur Arna Hilmarsdóttir 2000- |
| 13.4.2022 | Formulation of controlled release venlafaxine tablets | Hrönn Gunnarsdóttir 2000-; Ólafía Ósk Reynisdóttir 1998-; Selma Þóra Jóhannsdóttir 1998-; Ylfa Örk Hákonardóttir 1999- |
| 29.4.2025 | Formulation of Dual-Burst Release Tablets Using a Compression-Coating Method | Jóna María Aradóttir 1999-; Laila Þóroddsdóttir 2001-; Rawha Nasr Nasser 1995- |
| 25.4.2022 | Formulation of eye drops containing monocaprin and monolaurin for ophthalmia neonatorum infection | Reynir Logi Sigurðarson 1997- |
| 12.4.2022 | Formulation of sustained-release aspirin capsules | Rannveig Erlendsdóttir 1998-; Alexandra Rut Kjærnested 2000-; Rakel Rán Ákadóttir 1999-; Vildís Kristín Rúnarsdóttir 1999- |